Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

sLOX-1 in Ischemic Stroke & Transient Ischemic Attack

J Am Heart Assoc; ePub 2018 Jan 12; Skarpengland, et al

Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels are elevated in patients with ischemic stroke and transient ischemic attack (TIA) independent of cause and time since the ischemic event, a recent study found. Plasma sLOX-1 (n=232) and carotid plaque OLR1 gene expression (n=146) were evaluated in patients referred for carotid endarterectomy, as well as in health control plasma (n=81). Patients were categorized according to presence of acute ischemic stroke or TIA (n=35), ≤7 days, >7 days ≤3 months (n=90), >3 months (n=40), or no reported symptoms (n=67). Researchers found:

  • Patients with carotid atherosclerosis had increased plasma sLOX-1 levels compared with controls.
  • Plaque OLR1 mRNA levels were increased in carotid plaques compared with nonatherosclerosis vessels.
  • Patients with an acute ischemic stroke caused by atrial fibrillation had raised sLOX‐1 levels comparable to those with an acute ischemic cerebral event related to carotid atherosclerosis.
  • There were no differences in sLOX plasma levels or OLR1 gene expression when analyzed according to the time since relevant cerebral ischemic symptoms.
  • Patients with severe carotid atherosclerosis without any previous ischemic events had raised sLOX-1 levels.

Citation:

Skarpengland T, Skjelland M, Kong XY, et al. Increased levels of lectin-like oxidized low-density lipoprotein receptor-1 in ischemic stroke and transient ischemic attack. [Published online ahead of print January 12, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.117.006479.

This Week's Must Reads

Detection & Management of Resistant Hypertension, Hypertension; ePub 2018 Sep 13; Carey, et al

Does Aspirin Prevent CV Events in Older Adults?, N Engl J Med; ePub 2018 Sep 16; McNeil, et al

Timing of ICD Placement From Last Hospitalization for HF, Circulation; ePub 2018 Sep 13; Ambrosy, et al

FFR and Quality of Life After PCI, Circulation; ePub 2018 Sep 18; Nishi, et al

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Must Reads in Hypercholesterolemia

Racial Differences in Statin Use, JAMA Cardiol; ePub 2018 Jun 13; Nanna, et al

LLT Use in Patients with Elevated LDL-C, Circ Cardiovasc Qual Outcomes; ePub 2018 May 10; Virani, et al

Evolocumab in Differing Patient Populations , J Pharmacokinet Pharmacodyn; ePub 2018 May 7; Kuchimanchi, et al

LDL-C Targets in Elderly Statin Users After ACS, J Am Heart Assoc; ePub 2018 May 12; Alter, et al

Patient Perspectives on Statin Therapy, Clin Cardiol; ePub 2018 May 10; Brinton